Development of an integrated canine data commons (icdc)
Active Awarded Last action
- Contract number
- 75N91018F00076
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,811,851
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 91% obligated
-
- $9,811,851.00 Current, with exercised options
- $10,737,338.00 Potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $966,275 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $3,450,938 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $3,403,168 | |
| Original award | $1,991,470 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 24, 2018, for development of an Integrated Canine Data Commons (ICDC), with a ceiling value of $10.737 million and ultimate completion date of September 23, 2028. This is Modification 006, which increases the subcontracting ceiling and exercises an optional period.
The delivery order is issued under a cost-plus-fixed-fee pricing structure. Place of performance is Frederick, MD. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute.
Service Contract Inventory reporting shows actual government-invoiced labor across recent fiscal years. FY2024 (most recent) reflects 3.8 FTEs and 7,982 contractor hours invoiced at a derived blended rate of $148.51 per hour. FY2023 peaked at 6.7 FTEs and 13,935 contractor hours invoiced at $120.78 per hour. Across FY2021–FY2024, the blended derived hourly rate has risen. FY2024 reports one subcontractor engaged for 77 percent of contractor hours.
Quick answers
Who was awarded contract 75N91018F00076?
75N91018F00076 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2018.
How much is contract 75N91018F00076 worth?
The government has obligated $9,811,851 on 75N91018F00076. Its potential value, with all options, is $10,737,338.
Is contract 75N91018F00076 an order under another contract?
Yes. 75N91018F00076 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00076 competed?
The extent of competition for 75N91018F00076 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award